Thiamine as a Renal Protective Agent in Septic Shock
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo controlled study to investigate the effect of
intravenous thiamine (vitamin B1) on renal function in septic shock.